...
首页> 外文期刊>BMC Cardiovascular Disorders >Transvenous dual-chamber pacemaker implantation in patients with persistent left superior vena cava
【24h】

Transvenous dual-chamber pacemaker implantation in patients with persistent left superior vena cava

机译:持续性左上腔静脉持续患者的静脉双腔起搏器植入

获取原文
           

摘要

Persistent left superior vena cava (PLSVC) is a rare congenital vascular anomaly. Permanent pacemaker implantation (PPI) in patients with PLSVC can be challenging because of the venous anomalies. We reported a case series of patients with PLSVC who underwent PPI with double active fixation leads. From January 2012 to July 2016, 9 patients (three male and six females, mean age 68?±?11?years) with PLSVC who received a dual-chamber pacemaker with double active fixation leads were enrolled retrospectively in this observational study. The indications for pacemaker implantation were symptomatic third-degree atrioventricular block in one and sick sinus syndrome in eight patients. PPI were implanted successfully in all 9 patients. Successful positioning of the ventricular leads at the right ventricular outflow tract (RVOT) septum with a “C” shaped stylet was achieved in 7 patients (77.8%). In the remaining two cases, the ventricular leads were placed in the right ventricular apex and the inferior free wall of the sub-tricuspid annulus. The atrial leads were placed at the lateral wall of the right atrium in all patients. Procedure time and fluoroscopy time were 85.3?±?11.3?min and 4.5?±?1.1?min respectively. During a mean follow-up of 4?years, no complications were observed and pacing parameters did not change significantly. PPI through PLSVC may be technically feasible, safe, and effective. Double active fixation leads may be standard for patients with PLSVC and most of the ventricular leads could be placed at the RVOT septum.
机译:持续性左上腔静脉(PLSVC)是一种罕见的先天性血管异常。由于静脉异常,永久性起搏器植入(PPI)在PLSVC患者中可能具有挑战性。我们报道了一例PLSVC患者,他们接受了双重主动固定导线的PPI治疗。从2012年1月至2016年7月,本研究回顾性研究了9例PLSVC患者(3例男性和6例女性,平均年龄68?±?11?岁),他们接受了双腔起搏器和双重主动固定导联。起搏器植入的指征是有症状的三级房室传导阻滞1例和8例病态窦房结综合征。所有9例患者均成功植入了PPI。 7例患者(77.8%)成功地通过“ C”形探针将右室导线定位在右室流出道(RVOT)隔膜上。在其余的两种情况下,将心室导线放置在右心室顶点和三叉下环的下游离壁中。所有患者的心房导线均置于右心房的侧壁。手术时间和荧光检查时间分别为85.3±11.3min和4.5±1.1μmin。在平均随访4年期间,未观察到并发症,起搏参数也没有明显改变。通过PLSVC进行PPI可能在技术上可行,安全且有效。对于PLSVC患者,双主动固定导联可能是标准配置,大多数心室导联可以放置在RVOT隔垫处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号